• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度学习预测甲状腺癌启动子突变状态的组织学图像

Deep Learning Prediction of Promoter Mutation Status in Thyroid Cancer Using Histologic Images.

机构信息

Department of Pathology, Kyungpook National University School of Medicine, Kyungpook National University Chilgok Hospital, Daegu 41404, Republic of Korea.

Clinical Omics Institute, Kyungpook National University, Daegu 41405, Republic of Korea.

出版信息

Medicina (Kaunas). 2023 Mar 9;59(3):536. doi: 10.3390/medicina59030536.

DOI:10.3390/medicina59030536
PMID:36984536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10055833/
Abstract

objectives: Telomerase reverse transcriptase () promoter mutation, found in a subset of patients with thyroid cancer, is strongly associated with aggressive biologic behavior. Predicting promoter mutation is thus necessary for the prognostic stratification of thyroid cancer patients. In this study, we evaluate promoter mutation status in thyroid cancer through the deep learning approach using histologic images. Our analysis included 13 consecutive surgically resected thyroid cancers with promoter mutations (either C228T or C250T) and 12 randomly selected surgically resected thyroid cancers with a wild-type promoter. Our deep learning model was created using a two-step cascade approach. First, tumor areas were identified using convolutional neural networks (CNNs), and then promoter mutations within tumor areas were predicted using the CNN-recurrent neural network (CRNN) model. : Using the hue-saturation-value (HSV)-strong color transformation scheme, the overall experiment results show 99.9% sensitivity and 60% specificity (improvements of approximately 25% and 37%, respectively, compared to image normalization as a baseline model) in predicting mutations. : Highly sensitive screening for promoter mutations is possible using histologic image analysis based on deep learning. This approach will help improve the classification of thyroid cancer patients according to the biologic behavior of tumors.

摘要

目的

端粒酶逆转录酶()启动子突变存在于一部分甲状腺癌患者中,与侵袭性生物学行为密切相关。因此,预测启动子突变对于甲状腺癌患者的预后分层是必要的。本研究通过使用组织学图像的深度学习方法来评估甲状腺癌中的启动子突变状态。我们的分析包括 13 例连续手术切除的携带有突变(C228T 或 C250T)的甲状腺癌和 12 例随机选择的手术切除的野生型 启动子的甲状腺癌。我们的深度学习模型使用两步级联方法创建。首先,使用卷积神经网络(CNN)识别肿瘤区域,然后使用 CNN-递归神经网络(CRNN)模型预测肿瘤区域内的启动子突变。结果:使用色调-饱和度-值(HSV)强颜色变换方案,总体实验结果显示在预测突变方面具有 99.9%的灵敏度和 60%的特异性(与作为基线模型的图像归一化相比,分别提高了约 25%和 37%)。结论:基于深度学习的组织学图像分析可以实现对启动子突变的高度敏感筛查。这种方法将有助于根据肿瘤的生物学行为改善甲状腺癌患者的分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/7621c38de4da/medicina-59-00536-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/82ed194b9343/medicina-59-00536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/059317ebc419/medicina-59-00536-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/9d9ab709187d/medicina-59-00536-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/9126bf5f70f8/medicina-59-00536-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/16799b0dd3ba/medicina-59-00536-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/035b3c8b0077/medicina-59-00536-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/6ac559d51ddb/medicina-59-00536-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/a9252a13b842/medicina-59-00536-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/7621c38de4da/medicina-59-00536-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/82ed194b9343/medicina-59-00536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/059317ebc419/medicina-59-00536-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/9d9ab709187d/medicina-59-00536-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/9126bf5f70f8/medicina-59-00536-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/16799b0dd3ba/medicina-59-00536-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/035b3c8b0077/medicina-59-00536-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/6ac559d51ddb/medicina-59-00536-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/a9252a13b842/medicina-59-00536-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/10055833/7621c38de4da/medicina-59-00536-g009.jpg

相似文献

1
Deep Learning Prediction of Promoter Mutation Status in Thyroid Cancer Using Histologic Images.深度学习预测甲状腺癌启动子突变状态的组织学图像
Medicina (Kaunas). 2023 Mar 9;59(3):536. doi: 10.3390/medicina59030536.
2
Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.BRAF(V600E)突变高发人群中甲状腺乳头状癌TERT启动子突变的预后意义
Thyroid. 2016 Jul;26(7):901-10. doi: 10.1089/thy.2015.0488. Epub 2016 Jun 6.
3
TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.端粒酶逆转录酶(TERT)启动子突变及其与BRAF V600E突变和甲状腺癌侵袭性临床病理特征的关联。
J Clin Endocrinol Metab. 2014 Jun;99(6):E1130-6. doi: 10.1210/jc.2013-4048. Epub 2014 Mar 11.
4
Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.甲状腺癌中频繁的体细胞 TERT 启动子突变:在疾病的晚期形式中更为普遍。
J Clin Endocrinol Metab. 2013 Sep;98(9):E1562-6. doi: 10.1210/jc.2013-2383. Epub 2013 Jul 5.
5
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.在侵袭性甲状腺癌中普遍存在 TERT 启动子突变。
Endocr Relat Cancer. 2013 Jul 12;20(4):603-10. doi: 10.1530/ERC-13-0210. Print 2013 Aug.
6
TERT promoter mutations in thyroid cancer.甲状腺癌中的端粒酶逆转录酶(TERT)启动子突变
Endocr Relat Cancer. 2016 Mar;23(3):R143-55. doi: 10.1530/ERC-15-0533. Epub 2016 Jan 5.
7
The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.滤泡性甲状腺细胞来源癌中与年龄和端粒缩短相关的TERT启动子突变
Oncogene. 2014 Oct 16;33(42):4978-84. doi: 10.1038/onc.2013.446. Epub 2013 Oct 21.
8
Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report.具有转移倾向的端粒酶逆转录酶(TERT)启动子和 v-Raf 鼠肉瘤病毒癌基因同源物 B(BRAF)突变的甲状腺滤泡癌高细胞型变体,发生于异位甲状腺组织中:1 例报告。
Medicine (Baltimore). 2021 Jan 15;100(2):e24237. doi: 10.1097/MD.0000000000024237.
9
Arms-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers With Worse Prognosis Determined by Coexisting BRAF V600E and Tert Promoter Mutations.双臂实时定量聚合酶链反应提高了同时存在 BRAF V600E 和 TERT 启动子突变的预后较差的甲状腺乳头状癌早期诊断的检测灵敏度。
Endocr Pract. 2021 Jul;27(7):698-705. doi: 10.1016/j.eprac.2021.01.015. Epub 2021 Jan 27.
10
mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.mRNA 表达作为甲状腺乳头状癌的一种新型预后标志物。
Thyroid. 2019 Aug;29(8):1105-1114. doi: 10.1089/thy.2018.0695. Epub 2019 Aug 5.

引用本文的文献

1
Trends in AI-powered Classification of Thyroid Neoplasms Based on Histopathology Images - a Systematic Review.基于组织病理学图像的人工智能辅助甲状腺肿瘤分类研究进展——一项系统综述
Acta Inform Med. 2023;31(4):280-286. doi: 10.5455/aim.2023.31.280-286.
2
A study on the recognition of monkeypox infection based on deep convolutional neural networks.基于深度卷积神经网络的猴痘感染识别研究。
Front Immunol. 2023 Dec 7;14:1225557. doi: 10.3389/fimmu.2023.1225557. eCollection 2023.

本文引用的文献

1
Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide images.深度学习从全切片图像中识别管腔型乳腺癌同源重组缺陷的形态模式。
Cell Rep Med. 2022 Dec 20;3(12):100872. doi: 10.1016/j.xcrm.2022.100872. Epub 2022 Dec 13.
2
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma.甲状腺乳头状癌不同病理阶段瘤内异质性的演变
Cancer Cell Int. 2022 Aug 22;22(1):263. doi: 10.1186/s12935-022-02680-1.
3
DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer.
DeepSMILE:从结直肠癌和乳腺癌的 H&E 全切片图像中直接进行对比自监督预训练,有利于 MSI 和 HRD 分类。
Med Image Anal. 2022 Jul;79:102464. doi: 10.1016/j.media.2022.102464. Epub 2022 Apr 29.
4
Overview of the 2022 WHO Classification of Thyroid Neoplasms.2022 年世卫组织甲状腺肿瘤分类概述。
Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14.
5
Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis.泛癌计算组织病理学揭示了突变、肿瘤组成和预后。
Nat Cancer. 2020 Aug;1(8):800-810. doi: 10.1038/s43018-020-0085-8. Epub 2020 Jul 27.
6
Digital pathology and artificial intelligence in translational medicine and clinical practice.数字病理学与人工智能在转化医学及临床实践中的应用。
Mod Pathol. 2022 Jan;35(1):23-32. doi: 10.1038/s41379-021-00919-2. Epub 2021 Oct 5.
7
Detection of TERT Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error.使用靶向下一代测序检测 TERT 启动子突变:通过反复试验克服 GC 偏倚。
Cancer Res Treat. 2022 Jan;54(1):75-83. doi: 10.4143/crt.2021.107. Epub 2021 May 3.
8
Pan-cancer image-based detection of clinically actionable genetic alterations.泛癌症影像检测临床可操作的基因突变。
Nat Cancer. 2020 Aug;1(8):789-799. doi: 10.1038/s43018-020-0087-6. Epub 2020 Jul 27.
9
Data-efficient and weakly supervised computational pathology on whole-slide images.基于全切片图像的数据高效和弱监督计算病理学。
Nat Biomed Eng. 2021 Jun;5(6):555-570. doi: 10.1038/s41551-020-00682-w. Epub 2021 Mar 1.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.